Smartlab Europe

Drug Research

Simris Alg ab Signs Partnership Agreement With Lonza Ltd to Promote Its Adc Payload Technology

Simris Alg AB, a European biologics company focused on extracting high value biological active compounds from microalgae and cyanobacteria, announced a framework collaboration agreement with Lonza Ltd, a preferred partner to the pharmaceutical, biotech and nutraceutical markets, to commercialize...

Revolutionary Bone Cancer Treatment Developed By Researchers

Researchers from the University of East Anglia- UEA have come up with a new non-invasive treatment for bone cancer that happens to be effective against all primary forms of the disease. Notably, the current bone cancer treatment remains invasive...

Chronic Inflammations Can Get Thwarted-Off Due To T Cells

In cases when the body is subjected to cancer as well as chronic infections, cytotoxic T immune cells happen to be vital in defining the immune system. Abnormal as well as infected cells need to be eradicated in no...

Next Generation Proteomics Excel Singapore Precision Drugs

The National University of Singapore’s Yong Loo Lin School of Medicine has gone on to launch the NUS Medicine Protein Biomarker Discovery Core Facility, which will hand out the Olink Target 96 and 48, Olink Explore 3072, as well...

Guidance On mAbs, Therapeutic Proteins Potency Issued By FDA

The FDA has gone on to issue guidance on March 2, 2023 in order to give out recommendations to sponsors that will help in monoclonal antibodies- mAbs creation as well as other therapeutic proteins which go on to target...

Protein Drug Manufacturing May Get New Purification Method

In a recent study, researchers at the Massachusetts Institute of Technology (MIT) have come up with a new purification approach to reduce the cost of making protein drugs. So as to isolate proteins from a bioreactor rapidly and cheaply,...

IAVI, BARDA Expand Partnership to Advance Filovirus Vaccine Candidates

International AIDS Vaccine Initiative (IAVI) announced the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, funded additional development and testing of IAVI's...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »